Lista de obras - Isabelle Borget - Dominio Público Uruguay

131I effective half-life and dosimetry in thyroid cancer patients

artículo científico publicado en 2008

A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty

artículo científico publicado en 2015

A multicenter prospective observational study of the conformity of temozolomide prescriptions in France.

artículo científico publicado en 2012

Adrenocortical carcinoma

artículo científico publicado en 2015

Advantages and disadvantages of 3-dimensional printing in surgery: A systematic review.

artículo científico publicado en 2016

Anatomic Variability of the Upper Mediastinal Lymph Node Level VII.

artículo científico publicado en 2016

Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer.

artículo científico publicado en 2016

Application of an acceptance sampling plan for post-production quality control of chemotherapeutic batches in an hospital pharmacy

artículo científico publicado en 2006

Assessment of the cost of fine-needle aspiration cytology as a diagnostic tool in patients with thyroid nodules.

artículo científico publicado en 2008

Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs).

artículo científico publicado en 2017

Biosimilars and medico-economic aspects

artículo científico publicado en 2010

Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study

artículo científico publicado en 2013

Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer Patients

artículo científico publicado en 2017

Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database

artículo científico publicado en 2016

Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting

artículo científico

Companion Diagnostics-Targeted Therapies Pairings Model-Based Economic Evaluation: Reflection On A General Modeling Framework And Key Methodological Points

article

Correction: Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study ⬇️

scientific article published on 01 September 2018

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

artículo científico publicado en 2018

Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer. Results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 randomized trial

artículo científico publicado en 2006

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3.

artículo científico publicado en 2011

Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study

artículo científico publicado en 2014

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

artículo científico publicado en 2013

Diagnosis of HPV driven oropharyngeal cancers: Comparing p16 based algorithms with the RNAscope HPV-test.

artículo científico publicado en 2016

Dosimetric Effects of the Interfraction Variations during Whole Breast Radiotherapy: A Prospective Study.

artículo científico publicado en 2015

Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.

artículo científico publicado en 2012

Economic burden of HPV-related cancers in France

artículo científico publicado en 2011

Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review

artículo científico publicado en 2014

Editorial: Calcitonin determination in patients with nodular thyroid disease

artículo científico publicado en 2007

Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer.

artículo científico publicado en 2011

Evaluation of the accuracy of a computer-aided diagnosis (CAD) system in breast ultrasound according to the radiologist's experience.

artículo científico publicado en 2012

Existing reporting guidelines for clinical trials are not completely relevant for implantable medical devices: a systematic review.

artículo científico

Expected Impact of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) on Health Technology Assessment

article

F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients

scientific article published on 01 October 2019

Factors associated with excessively lengthy treatment of tuberculosis in the eastern Paris region of France in 2004.

artículo científico publicado en 2010

Factors influencing posaconazole plasmatic concentrations in patients presenting with acute myeloid leukemia

artículo científico publicado en 2014

Follow-up of differentiated thyroid cancer - what should (and what should not) be done

artículo científico publicado en 2018

French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends

artículo científico publicado en 2015

French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future Trends.

artículo científico publicado en 2016

Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy

artículo científico publicado en 2013

Frequency and intensity of pain related to thyroid nodule fine-needle aspiration cytology.

artículo científico publicado en 2013

HARMONIZING HEALTH TECHNOLOGY ASSESSMENT PRACTICES IN UNIVERSITY HOSPITALS: TO WHAT EXTENT IS THE MINI-HTA MODEL SUITABLE IN THE FRENCH CONTEXT?

artículo científico publicado en 2017

HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT FOR THE ADOPTION OF INNOVATIVE MEDICAL DEVICES WITHIN FRENCH HOSPITALS: OPPORTUNITIES AND CHALLENGES FOR INDUSTRY.

artículo científico publicado en 2017

Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database.

artículo científico publicado en 2010

Health-related quality of life--an economist's perspective

artículo científico publicado en 2007

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

artículo científico publicado en 2015

High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up

scientific article published on 02 November 2011

Hospital Cost of Thromboembolic Events in Breast or Prostate Cancer Patients.

artículo científico publicado en 2014

INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES.

artículo científico publicado en 2015

Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments

artículo científico publicado en 2020

Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

artículo científico publicado en 2014

Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer.

artículo científico publicado en 2013

Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma

scientific article published on 01 August 2013

Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physicians.

artículo científico publicado en 2015

Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients.

artículo científico publicado en 2017

Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen

artículo científico publicado en 2008

Lenvatinib for the treatment of radio-iodine refractory thyroid cancer in real-life practice.

artículo científico publicado en 2017

Les indicateurs médico-économiques et l’innovation en oncologie thoracique

article

Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients

artículo científico publicado en 2014

Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancer

artículo científico publicado en 2020

Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients

artículo científico publicado en 2011

Management and treatment outcomes of tuberculous patients, eastern Paris, France, 2004.

artículo científico publicado en 2009

Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).

artículo científico publicado en 2015

Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs

artículo científico publicado en 2014

Molecular screening for a personalized treatment approach in advanced adrenocortical cancer

artículo científico publicado en 2013

New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues.

artículo científico publicado en 2015

O-060 Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: A Markov analysis

Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy

One-Year Progression-Free Survival of Therapy-Naive Patients With Malignant Pheochromocytoma and Paraganglioma

artículo científico publicado en 2013

Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial

scientific article published on 26 May 2018

PCN10 INCREMENTAL COST-EFFECTIVENESS RATIO OF DARBEPOETIN ALFA (ARANESP®) IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER PATIENTS

PCN109 Cost Effectiveness of First Line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: A Markov Model

PCN42 Treatment Costs of Bone Metastases in Patients with Lung Cancer: Results From A French Prospective, Observational, Multicenter Study (GFPC 0601)

article

PCN81 COST-EFFECTIVENESS ANALYSIS OF THREE STRATEGIES OF ERLOTINIB TREATMENT IN NON0-SMALL-CELL LUNG CANCER:A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)

article

PCN97 COST EFFECTIVENESS OF ERLOTINIB TREATMENT GIVEN BY A CLINICALLY BASED APPROACH AND AN EGFR/KRAS TESTING-GUIDED APPROACH ADVANCED IN NON SMALL-CELL LUNG CANCER: A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)

article

Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level.

artículo científico publicado en 2011

Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma.

artículo científico publicado en 2015

Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.

artículo científico publicado en 2015

Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels

artículo científico publicado en 2012

Prescription guidebook for temozolomide usage in brain tumors

artículo científico publicado en 2009

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study

scientific article published on 01 June 2019

Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.

artículo científico publicado en 2015

Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group

artículo científico publicado en 2017

Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers

artículo científico publicado en 2013

Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer

artículo científico publicado en 2012

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates

Prophylactic level II neck dissection guided by frozen section for clinically node-negative papillary thyroid carcinoma: is it useful?

artículo científico publicado en 2014

Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial

artículo científico publicado en 2015

Qualité de vie et traitement de l’anémie chimio-induite dans le cancer bronchopulmonaire : étude prospective

RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric study

artículo científico publicado en 2017

Radioactive iodine ablation in low-risk thyroid cancer - Authors' reply

artículo científico publicado en 2018

Role of meta-analyses and of large randomized trials in the study of cancer treatments.

scientific article published on 06 December 2008

Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: a Markov analysis

artículo científico publicado en 2006

SDHBmutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

article

Safety and quality assurance of chemotherapeutic preparations in a hospital production unit: acceptance sampling plan and economic impact

artículo científico publicado en 2011

Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up

artículo científico publicado en 2015

Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal.

artículo científico publicado en 2007

Single-use flexible bronchoscopes compared with reusable bronchoscopes: Positive organizational impact but a costly solution.

artículo científico publicado en 2018

Strategies of radioiodine ablation in patients with low-risk thyroid cancer

artículo científico publicado en 2012

Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors

artículo científico publicado en 2017

Targeted Therapies in Non–Small-Cell Lung Cancer Management: No Cost-Effective Strategies?

artículo científico publicado en 2014

The American Society of Clinical Oncology (Asco) Net Health Benefit (Nhb) Assessment Tool: Which Implications for Value Assessment of Cancer Therapies?

article

The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic

artículo científico publicado en 2016

The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in France

artículo científico publicado en 2015

The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer.

artículo científico publicado en 2016

The learning curve in transcatheter aortic valve implantation clinical studies: A systematic review

scientific article published on 21 April 2020

The medical treatment of radioiodine-refractory differentiated thyroid cancers in 2019. A TUTHYREF® network review

scientific article published on 11 June 2019

Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?

artículo científico

Thyroid cancer patients treated with 131I: radiation dose to relatives after discharge from the hospital

artículo científico publicado en 2011

Treatment and follow-up of low-risk patients with thyroid cancer

artículo científico publicado en 2011

Treatment of lung cancer: will financial issues become a criterion of choice?

artículo científico publicado en 2013

Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.

artículo científico publicado en 2014

Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation.

artículo científico publicado en 2013

Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents

artículo científico publicado en 2013

Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful?

artículo científico publicado en 2017

Value of cardiophrenic angle lymph node for the diagnosis of colorectal peritoneal carcinomatosis.

artículo científico publicado en 2013

Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort

artículo científico publicado en 2015

[A prospective study of quality of life and treatment of chemotherapy-induced anaemia in lung cancer]

artículo científico publicado en 2007

[Cost-effectiveness of darbepoetin alpha in an every-3-weeks schedule]

artículo científico publicado en 2008

Évaluation gériatrique et morbidité après exérèse pulmonaire pour cancer bronchique

scientific article published on 01 May 2010

Lista de obras de Isabelle Borget

131I effective half-life and dosimetry in thyroid cancer patients

A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty

A multicenter prospective observational study of the conformity of temozolomide prescriptions in France.

Adrenocortical carcinoma

Advantages and disadvantages of 3-dimensional printing in surgery: A systematic review.

Anatomic Variability of the Upper Mediastinal Lymph Node Level VII.

Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer.

Application of an acceptance sampling plan for post-production quality control of chemotherapeutic batches in an hospital pharmacy

Assessment of the cost of fine-needle aspiration cytology as a diagnostic tool in patients with thyroid nodules.

Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs).

Biosimilars and medico-economic aspects

Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study

Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer Patients

Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database

Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting

Companion Diagnostics-Targeted Therapies Pairings Model-Based Economic Evaluation: Reflection On A General Modeling Framework And Key Methodological Points

Correction: Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study ⬇️

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

Cost-effectiveness analysis of first-line chemotherapies in metastatic colorectal cancer. Results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 randomized trial

Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3.

Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

Diagnosis of HPV driven oropharyngeal cancers: Comparing p16 based algorithms with the RNAscope HPV-test.

Dosimetric Effects of the Interfraction Variations during Whole Breast Radiotherapy: A Prospective Study.

Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.

Economic burden of HPV-related cancers in France

Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review

Editorial: Calcitonin determination in patients with nodular thyroid disease

Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer.

Evaluation of the accuracy of a computer-aided diagnosis (CAD) system in breast ultrasound according to the radiologist's experience.

Existing reporting guidelines for clinical trials are not completely relevant for implantable medical devices: a systematic review.

Expected Impact of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) on Health Technology Assessment

F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients

Factors associated with excessively lengthy treatment of tuberculosis in the eastern Paris region of France in 2004.

Factors influencing posaconazole plasmatic concentrations in patients presenting with acute myeloid leukemia

Follow-up of differentiated thyroid cancer - what should (and what should not) be done

French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends

French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future Trends.

Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy

Frequency and intensity of pain related to thyroid nodule fine-needle aspiration cytology.

HARMONIZING HEALTH TECHNOLOGY ASSESSMENT PRACTICES IN UNIVERSITY HOSPITALS: TO WHAT EXTENT IS THE MINI-HTA MODEL SUITABLE IN THE FRENCH CONTEXT?

HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT FOR THE ADOPTION OF INNOVATIVE MEDICAL DEVICES WITHIN FRENCH HOSPITALS: OPPORTUNITIES AND CHALLENGES FOR INDUSTRY.

Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database.

Health-related quality of life--an economist's perspective

High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer

High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-up

Hospital Cost of Thromboembolic Events in Breast or Prostate Cancer Patients.

INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES.

Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental Treatments

Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer.

Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma

Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physicians.

Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients.

Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen

Lenvatinib for the treatment of radio-iodine refractory thyroid cancer in real-life practice.

Les indicateurs médico-économiques et l’innovation en oncologie thoracique

Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients

Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancer

Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients

Management and treatment outcomes of tuberculous patients, eastern Paris, France, 2004.

Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).

Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs

Molecular screening for a personalized treatment approach in advanced adrenocortical cancer

New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues.

O-060 Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: A Markov analysis

Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy

One-Year Progression-Free Survival of Therapy-Naive Patients With Malignant Pheochromocytoma and Paraganglioma

Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial

PCN10 INCREMENTAL COST-EFFECTIVENESS RATIO OF DARBEPOETIN ALFA (ARANESP®) IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER PATIENTS

PCN109 Cost Effectiveness of First Line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: A Markov Model

PCN42 Treatment Costs of Bone Metastases in Patients with Lung Cancer: Results From A French Prospective, Observational, Multicenter Study (GFPC 0601)

PCN81 COST-EFFECTIVENESS ANALYSIS OF THREE STRATEGIES OF ERLOTINIB TREATMENT IN NON0-SMALL-CELL LUNG CANCER:A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)

PCN97 COST EFFECTIVENESS OF ERLOTINIB TREATMENT GIVEN BY A CLINICALLY BASED APPROACH AND AN EGFR/KRAS TESTING-GUIDED APPROACH ADVANCED IN NON SMALL-CELL LUNG CANCER: A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)

Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level.

Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma.

Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.

Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels

Prescription guidebook for temozolomide usage in brain tumors